March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Jennifer Johnsen, MD, MPH, Managing Editor
Pain is common in people living with HIV. Understand common types of pain, what to do if you have pain, and ways to manage or treat pain.
Our community advisory board is composed of a group of women living with HIV who provide us with their guidance as we develop and offer our programming.